Brain-derived Neurotrophic Factor in the Aqueous Humor of Glaucoma Patients.


Journal

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
ISSN: 1347-3409
Titre abrégé: J Nippon Med Sch
Pays: Japan
ID NLM: 100935589

Informations de publication

Date de publication:
2021
Historique:
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 27 10 2021
Statut: ppublish

Résumé

Brain-derived neurotrophic factor (BDNF) may be involved in the pathogenesis of glaucoma. BDNF concentrations reported in previous studies have varied widely, and the concentration of BDNF in aqueous humor is unknown. In this study, BDNF concentrations in the aqueous humor of glaucoma patients and control patients were measured with ELISA kits. This prospective, observational study examined BDNF levels in aqueous humor in 62 eyes of 43 patients who underwent cataract surgery or trabeculectomy (11 glaucoma patients and 32 non-glaucoma cataract patients as controls). BDNF concentrations were examined by 4 different enzyme-linked immunosorbent assay (ELISA) techniques. The mean ± SD patient age was 72.0 ± 10.1 (range 35 to 87) years. Two of the techniques detected no BDNF in aqueous humor in any samples (n=3 and n=9, respectively); the average value was less than zero. An ultrasensitive ELISA kit did not yield reliable measurements. Finally, in an even more sensitive ELISA (Simoa-HD1), performed by an outside contractor, 25 (54.3%) eyes were below the detection limit, including 20 (55.6%) control and 5 (50%) glaucoma cases. For eyes with detectable BDNF, the overall BDNF concentration was 0.158 pg/mL (n=21): 0.196 pg/mL (n=16) in controls and 0.034 pg/mL (n=5) in glaucoma cases. BDNF level in aqueous humor varies widely.

Sections du résumé

BACKGROUND BACKGROUND
Brain-derived neurotrophic factor (BDNF) may be involved in the pathogenesis of glaucoma. BDNF concentrations reported in previous studies have varied widely, and the concentration of BDNF in aqueous humor is unknown. In this study, BDNF concentrations in the aqueous humor of glaucoma patients and control patients were measured with ELISA kits.
METHODS METHODS
This prospective, observational study examined BDNF levels in aqueous humor in 62 eyes of 43 patients who underwent cataract surgery or trabeculectomy (11 glaucoma patients and 32 non-glaucoma cataract patients as controls). BDNF concentrations were examined by 4 different enzyme-linked immunosorbent assay (ELISA) techniques.
RESULTS RESULTS
The mean ± SD patient age was 72.0 ± 10.1 (range 35 to 87) years. Two of the techniques detected no BDNF in aqueous humor in any samples (n=3 and n=9, respectively); the average value was less than zero. An ultrasensitive ELISA kit did not yield reliable measurements. Finally, in an even more sensitive ELISA (Simoa-HD1), performed by an outside contractor, 25 (54.3%) eyes were below the detection limit, including 20 (55.6%) control and 5 (50%) glaucoma cases. For eyes with detectable BDNF, the overall BDNF concentration was 0.158 pg/mL (n=21): 0.196 pg/mL (n=16) in controls and 0.034 pg/mL (n=5) in glaucoma cases.
CONCLUSIONS CONCLUSIONS
BDNF level in aqueous humor varies widely.

Identifiants

pubmed: 33980757
doi: 10.1272/jnms.JNMS.2021_88-305
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-132

Auteurs

Tsutomu Igarashi (T)

Department of Ophthalmology, Nippon Medical School.

Kenji Nakamoto (K)

Department of Ophthalmology, Nippon Medical School.

Maika Kobayashi (M)

Department of Ophthalmology, Nippon Medical School.

Hisaharu Suzuki (H)

Department of Ophthalmology, Nippon Medical School.

Takeshi Arima (T)

Department of Ophthalmology, Nippon Medical School.

Yutaro Tobita (Y)

Department of Ophthalmology, Nippon Medical School.

Kazuhiro Takao (K)

Department of Ophthalmology, Nippon Medical School.

Toru Igarashi (T)

Department of Pediatrics, Nippon Medical School.

Takahisa Okuda (T)

Division of Legal Medicine, Department of Social Medicine, Nihon University School of Medicine.

Takashi Okada (T)

Division of Molecular and Medical Genetics, The Institute of Medical Science, The University of Tokyo.

Hiroshi Takahashi (H)

Department of Ophthalmology, Nippon Medical School.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH